MedPath

Takeda Manufacturing Austria AG

🇦🇹Austria
Ownership
Subsidiary
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

54

CIMA_AEMPS:27
SFDA:15
NMPA:6
+1 more agencies

Drug Approvals

Recombinant Human Coagulation Factor Ⅷ For Injection

Product Name
百因止
Approval Number
国药准字SJ20170023
Approval Date
Dec 20, 2023
NMPA

Recombinant Human Coagulation Factor Ⅷ For Injection

Product Name
百因止
Approval Number
国药准字SJ20170021
Approval Date
Dec 20, 2023
NMPA

Recombinant Human Coagulation Factor Ⅷ For Injection

Product Name
百因止
Approval Number
国药准字SJ20170020
Approval Date
Dec 20, 2023
NMPA

Recombinant Human Coagulation Factor Ⅷ For Injection

Product Name
百因止
Approval Number
国药准字SJ20170022
Approval Date
Dec 20, 2023
NMPA

Human Albumin

Product Name
人血白蛋白
Approval Number
国药准字SJ20160018
Approval Date
Mar 21, 2023
NMPA

Human Albumin

Product Name
人血白蛋白
Approval Number
国药准字SJ20180020
Approval Date
Feb 20, 2023
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.